대한뇌혈류대사학회 제14차 온라인 심포지엄 연사 소개
대한뇌혈류대사학회 제14차 온라인 심포지엄 연사 소개
성균관대학교
h.cho@g.skku.edu
약력
Dec. 2023 – present NeuroLynx Ltd. Republic of Korea CEO
Sep. 2019 – present Dep. Biophysics, Sungkyunkwan University Associate Professor
July 2017 – June 2018 National University of Singapore Visiting Research Scientist
Aug. 2014 – June 2020 Mechanical Engineering and Engineering Science, Assistant Professor
University of North Carolina at Charlotte, Postdoctoral Research Fellow
Sep. 2010 – Aug. 2014 Harvard Medical School, Massachusetts General Hospital,
and Shriners Hospital
Jan. 2003 – Aug. 2005 Korea Institute of Science and Technology Research Scientist
Mar. 1999 – Jan. 2003 Biomedlab Co. Republic of Korea Team Manager
강의제목
3D Neurovascular-Glial Micro-Pathophysiological System
강의내용
The choroid plexus, where the blood-cerebrospinal fluid barrier (BCB) is located, plays a crucial role in regulating the entry of immune cells and molecules into the brain as well as removing neurotoxic substances. However, the study of BCB pathologies is challenging in the absence of simple and relevant models. Here, we present a blood-choroid plexus microphysiological system that integrates the choroid plexus, monocytes, macrophages, and blood-brain barrier (BBB) tissue chips to simulate the effects of neurotoxic substances in the BCB region. First, we validated the functional properties of BCB models by showing the restriction of monocytes, the leakage of FICT-dextran dye (M.W. 70 kDa) from blood-to-brain, the localization of ZO-1 and VE-cad in both brain endothelium and choroid plexus epithelium, and cuiboidal structures in the choroid plexus epithelium. Second, we confirmed the dysfunction of the blood-barrier side in the blood-to-CSF entry pathway by demonstrating that direct exposure of the BBB to LPS (10 ng/ml) and PFF (100 ng/ml) results in an increase in blood-barrier permeability, a reduction of ZO-1 and VE-Cad in endothelium, and the deposition of monocytes and macrophages into the CSF region, causing inflammation. Third, we reported that deposition of oligomer amyloid beta (100 ng/ml) in the CSF region induced choroid plexus epithelium dysfunction, as evidenced by a decrease in ZO-1 and TTR expression as well as the infusion of monocytes and macrophages into the CSF. We anticipate that our human blood-choroid plexus model will facilitate the elucidation of blood-cerebrospinal fluid barrier (BCB) pathophysiology and contribute to the development of therapeutic agents for neurodegenerative disease.
관련 논문
1 M. Tran, H.W. Jeong, M. An, C. Been, A. Jamsranjav, S.M. Kwak, L.P. Lee, H. Cho, “A 3D Gut-Brain-Vascular Platform for Bidirectional Crosstalk in Gut-Neuropathogenesis,” Nature Communications 2026, accepted
2 Y.J. Kang, Y.N. Diep, M. Tran, V.T.A Tran, G. Ambrin, H. Ngo, H. Cho*, “Three-dimensional Human Neural Culture on a Chip Recapitulating Neuroinflammation and Neurodegeneration,” Nature Protocols 2023, 18;9: 2838 (cover imaged)
3 H. Cho, J.H. Seo, K.H.K. Wong, Y. Terasaki, J. Park, K. Bong, K. Arai, E.H. Lo, D. Irimia, “Three-Dimensional Blood-Brain Barrier Model for in
vitro Studies of Neurovascular Pathology,” Scientific Reports 2015, 5:15222